Description: This session will focus on US GAAP accounting for life insurance and annuity transactions from an actuarial valuation perspective. With the high volume of recent M&A and reinsurance activity, many companies are onboarding blocks of business and performing Purchase GAAP or PGAAP-like exercises. Methodologies for establishing liabilities and intangible balances often vary based on the unique aspects of each transaction. This first half of this session will provide an overview of PGAAP elements and considerations, while the second half will dive into examples using interactive case studies. By attending this session, you will learn: Perspectives and approaches for initiating reserves and intangible balances when onboarding a new block of business

Description: Session 3A: State-Specific Enrollment Modeling - Understanding Disenrollment Trends and Population Dynamics

Description: Explore the value and cost of prescription drugs, how they should be defined and measured and the effects various stakeholders in the pharmacy ecosystem can have on these factors in the latest webcast. You'll investigate the impact of coverage, formulary and rebate negotiations and related benefit design. Find out how actuaries can answer questions related to the prescription drug industry, in addition to improving the access, quality and affordability of prescription drugs in the United States. Join us for this webcast and come learn about value-based contract design, negotiations, implementation and administration for prescription drugs.

Description: As the size of the life reinsurance market in Bermuda has grown to over half a trillion dollars at the end of 2021, more and more actuaries are getting involved with this 21 square mile North Atlantic island in one way or the other. Come explore a fundamental understanding of the Bermuda solvency framework and an overview of its upcoming changes.

Description: Modern Actuarial work, being quite data intensive, provides many opportunities for actuaries to use the statistical skills that are part of their basic training. Furthermore, modern computing allows us to analyze vast quantities of data intensively, and each package will provide statistical 'answers' to any questions the actuary might ask of it. However, in this particular field, it is often worth taking a step back, and ensuring that we recall and consider the warnings that come with each of the statistical procedures we might attempt to use. This will allow us to ensure that we guard ourselves against drawing inappropriate conclusions, which could come back to haunt us later.At the conclusion of the session, attendees will be able to avoid drawing inappropriate statistical conclusions, while doing their work. They will leave informed about the types of pitfalls that exist, and where those might come into play in actuarial work.

Description: Disability and group life products can pose challenges for the valuation actuary due to the long-tail runout of traditional disability and group life waiver of premium claims, and due to the sensitivity of the reserves to small changes in assumptions. This session addresses a number of issues of interest to actuaries who work with these products, including recent experience trends and the new 2023 Group Life Waiver Valuation Table. Attendees will learn about best practices in the valuation of these products.

Description: This session will cover everything you've wanted to know about GLMs but were too afraid to ask. How do these generalized models relate to the plain linear regression, and how can we be sure that the models we implement are appropriate for the task at hand?

Description: This panel discussion will focus on how companies have been able to take advantage of the new US GAAP requirements, to develop and refine other performance indicators that provide additional insights into their business.

Description: Session 1D: Meeting the Mark - Predicting MA Stars Outcomes with Monte Carlo Simulations

Description: Actuarial funding of OPEB plans is primarily a public sector phenomenon due to the different regulations and tax laws that impact private sector organizations in the US. OPEB funding started to gain momentum with the implementation of GASB Statement 45 in the mid to late 2000s.